Camlin Fine Sciences Share Price Today | Stock Price & Camlin Fine Sciences Share Screener
As of October 5, 2026, the live Camlin Fine Sciences share price (NSE: CAMLINFINE) is ₹91.16 on NSE and ₹91.24 on BSE, up 0.16% from the previous close, with shares trading between ₹89.69 and ₹93.20 in today's trading session, and a 52-week range of ₹91.01–₹201.32. Check CAMLINFINE price range for the annual price range and momentum. Use the Camlin Fine Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Camlin Fine Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹523 and net income of ₹-34, with EBITDA of ₹-1, an operating margin of -1.0% and a profit margin of -6.5%.
Camlin Fine Sciences Share Price Chart
Track the current stock price of Camlin Fine Sciences with an interactive chart. Analyse CAMLINFINE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Camlin Fine Sciences stock quote in one place.
The quote of ₹91.16 sits between the 52-week low of ₹91.01 and the 52-week high of ₹201.32, and the latest session moved 0.16% from the previous close.
Camlin Fine Sciences Company Profile - Fundamental Screener
Screen Camlin Fine Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CAMLINFINE shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE052I01032.
Company Details
Classification
Identifiers and Leadership
Camlin Fine Sciences Balance Sheet Screener
Screen CAMLINFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹2,324, up from ₹2,024 in 2025.
Latest statistics put total assets at ₹2,324 and shareholder funds at ₹1,001, with a leverage ratio of 0.71.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 2,324 | 2,024 | 1,952 | 2,060 | 1,800 | 1,482 | 1,234 | 1,087 | 1,017 | 673 |
| Current Assets | 1,234 | 1,183 | 1,001 | 1,088 | 894 | 795 | 675 | 673 | 666 | 419 |
| Fixed Assets | 887 | 704 | 816 | 858 | 601 | 584 | 306 | 272 | 278 | 201 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 349 | 303 | 363 | 443 | 440 | 291 | 226 | 196 | 112 | 57 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1,001 | 875 | 857 | 824 | 765 | 713 | 460 | 430 | 433 | 230 |
| Share Capital | 19 | 19 | 17 | 16 | 16 | 13 | 12 | 12 | 12 | 10 |
| Reserves & Surplus | 1,018 | 880 | 845 | 800 | 729 | 582 | 388 | 335 | 359 | 202 |
Camlin Fine Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Camlin Fine Sciences income statement and profit fundamentals. Analyze CAMLINFINE quarterly results. Camlin Fine Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹523 and net profit was ₹-34, equal to earnings per unit of ₹-1.65, at an operating margin of -1%.
In that period expenses were ₹524, interest cost ₹14 and tax ₹-1. The next period listed, 2026-Mar, shows revenue of ₹535 and net profit of ₹86.
| Item | 2026-Jun | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 523 | 535 | 445 | 415 | 464 | 443 | 382 | 383 | 429 | 432 | 429 | 426 | 408 | 388 | 411 |
| Expenses | 524 | 412 | 405 | 395 | 436 | 447 | 446 | 368 | 529 | 384 | 393 | 381 | 381 | 363 | 365 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | -1 | 124 | 40 | 20 | 29 | -4 | -64 | 14 | -100 | 48 | 36 | 45 | 27 | 25 | 46 |
| Operating Profit % | -1.00% | 3.00% | 6.00% | 3.00% | 5.00% | -1.00% | -19.00% | 3.00% | -27.00% | 11.00% | 8.00% | 9.00% | 6.00% | 6.00% | 6.00% |
| Depreciation | 19 | 21 | 17 | 16 | 19 | 16 | 13 | 15 | 17 | 15 | 18 | 19 | 19 | 21 | 16 |
| Interest | 14 | 23 | 15 | 15 | 19 | 17 | 16 | 23 | 26 | 34 | 10 | 10 | 20 | 14 | 10 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -34 | 80 | 8 | -11 | -9 | -37 | -94 | -24 | -142 | 0 | 8 | 16 | -12 | -10 | 20 |
| Tax | -1 | -6 | 8 | 0 | 6 | 0 | -12 | 11 | -26 | 7 | 5 | 4 | 9 | 5 | 7 |
| Net Profit | -34 | 86 | 0 | -11 | -15 | -37 | -82 | -35 | -116 | -8 | 4 | 12 | -21 | -14 | 13 |
| EPS | -1.65 | 4.59 | -1.25 | -0.53 | -0.76 | -2.38 | -4.64 | -2.00 | -5.88 | -0.71 | 0.59 | 0.96 | -1.17 | -0.71 | 1.16 |
Camlin Fine Sciences Cash Flow Screener - Liquidity Fundamentals
Screen CAMLINFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹82, and net cash flow was an inflow of ₹5.
Over the same period, investing activities used ₹53 and financing activities used ₹25.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 82 | 23 | 139 | 51 | 145 | 117 | 86 | -9 | -15 | -9 |
| Investing Activities | -53 | -75 | -67 | -125 | -249 | -133 | -90 | -2 | -149 | -70 |
Financing and Net Cash | ||||||||||
| Financing Activities | -25 | 76 | -86 | 60 | 136 | 39 | 3 | 26 | 182 | 91 |
| Net Cash Flow | 5 | 24 | -14 | -14 | 32 | 23 | -1 | 15 | 18 | 13 |
Camlin Fine Sciences Shareholding Pattern Screener
See Camlin Fine Sciences shareholding pattern with promoter, FII, and DII holdings. Check Camlin Fine Sciences promoter holding and ownership changes for CAMLINFINE on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 48.03%, foreign institutions 0.91%, domestic institutions 5.42% and the public 29.43%, spread across 55,178 shareholders.
The shareholder count was 55,178 in 2026-Jun, compared with 52,232 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Nov | 2025-Sept | 2025-Jun | 2025-Mar | 2025-Jan |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 48.03% | 48.03% | 48.03% | 48.03% | 49.08% | 49.10% | 49.10% | 49.10% |
Institutional Investors | ||||||||
| FII Holding | 0.91% | 0.94% | 2.12% | 2.15% | 2.12% | 2.88% | 1.47% | 0.82% |
| DII Holding | 5.42% | 7.70% | 7.77% | 7.78% | 5.48% | 4.14% | 3.83% | 4.09% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.43% | 28.28% | 26.94% | 26.89% | 29.20% | 30.98% | 32.85% | 33.14% |
| Other Holding | 16.21% | 15.05% | 15.13% | 15.15% | 14.13% | 12.89% | 12.75% | 12.85% |
| Shareholder Count | 55,178 | 52,232 | 57,661 | 52,845 | 57,661 | 59,538 | 58,111 | 60,554 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Camlin Fine Sciences. Camlin Fine Sciences dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Camlin Fine Sciences Stock Index Membership - Nifty & Sensex
See which indices include Camlin Fine Sciences stock. Check CAMLINFINE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 3 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP.
Complete Index List
Camlin Fine Sciences Market Events Screener - Corporate Actions
Get Camlin Fine Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Camlin Fine Sciences stock events that may affect CAMLINFINE share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 11, 2026, with a record date of August 11, 2026.
It is followed by Annual General Meeting dated August 11, 2026 and Quarterly Result Announcement dated May 26, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | -3.04% |
| 2026-08-11 | 2026-08-11 | Annual General Meeting | NA | 1.30% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -0.97% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | -3.72% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.05% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -8.63% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 26.19% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 9.49% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 5.94% |
| 2025-01-08 | 2025-01-08 | Rights | 5:41 | -2.16% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 16.05% |
| 2024-07-31 | 2024-07-31 | Annual General Meeting | NA | 19.06% |
Camlin Fine Sciences Competitors Screener - Peer Stocks Comparison
Screen CAMLINFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 151,430 | 55.96 | 14,867 | 11.05% | 2,471 | 36.09 |
| SRF | 72,921 | 34.14 | 15,894 | 7.20% | 1,835 | 40.37 |
| Gujarat Fluorochemicals | 48,661 | 79.48 | 5,126 | 5.63% | 574 | 43.64 |
| Navin Fluorine International | 42,429 | 52.85 | 3,379 | 41.21% | 664 | 46.95 |
| Himadri Speciality Chemical | 33,294 | 41.78 | 4,832 | 3.60% | 755 | 43.18 |
| Aether Industries | 22,046 | 94.34 | 1,181 | 34.17% | 220 | 51.01 |
| Deepak Nitrite | 20,418 | 26.00 | 7,947 | -5.01% | 551 | 29.76 |
| Atul | 17,241 | 21.26 | 6,476 | 13.77% | 689 | 28.75 |
| Aarti Industries | 17,073 | 31.75 | 8,291 | 13.78% | 419 | 40.04 |
| Fine Organic Industries | 15,974 | 35.89 | 2,483 | 4.89% | 417 | 56.96 |
Camlin Fine Sciences Company Announcements - News & Reports Screener
Screen CAMLINFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 24, 2026.
The next most recent announcements are dated September 16, 2026 and September 15, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-24 | Closure of Trading Window | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-15 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of Board Meeting Dated August 11 2026 | - |
| 2026-08-11 | Un-Audited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-11 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-11 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-04 | Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-07-28 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-18 | Announcement Under Regulation 30 (LODR) - Letter Sent To Shareholders. | - |
| 2026-07-18 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-18 | Notice Of 33Rd AGM Of The Company. | - |
| 2026-07-18 | Reg. 34 (1) Annual Report. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹91.16, within a 52-week range of ₹91.01 to ₹201.32. The P/E ratio is 3037.67 and the P/B ratio is 1.69, with earnings per unit of ₹1.46. Market capitalisation stands at ₹1,751.15 Cr. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.